Lv5
1090 积分 2024-01-11 加入
NSCLC: Five trials to watch
17小时前
待确认
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
13天前
已完结
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
13天前
已完结
Influence of Cycles of Neoadjuvant Chemoimmunotherapy on Treatment Response in Stage IIIA–N2IIIB Non-small Cell Lung Cancer: Experience from a Large-Volume Center
17天前
已完结
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
3个月前
已完结
Cisplatin plus etoposide versus other platin‐based regimens for patients with extensive small‐cell lung cancer: a systematic review and meta‐analysis of randomised, controlled trials
3个月前
已完结
Relationship between the tumor microenvironment and the efficacy of the combination of radiotherapy and immunotherapy
3个月前
已完结
Thoracic radiotherapy plus maintenance durvalumab after first line carboplatin and etoposide plus durvalumab in extensive-stage disease small cell lung cancer (ES-SCLC) – A multicenter single arm open label phase II trial (SAKK 15/19)
4个月前
已完结
[Expert consensus on diagnosis and treatment of advanced non-small cell lung cancer with HER-2 alterations (2025 edition)]
4个月前
已完结
靶向HER2 的抗体药物偶联物应用进展
4个月前
已完结
皖公网安备34019202002308
